Author: Beaujouan J.-C. Saffroy M. Torrens Y. Glowinski J.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.319, Iss.2, 1997-01, pp. : 307-316
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Nenan S. Germain N. Lagente V. Emonds-Alt X. Advenier C. Boichot E.
European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. :
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :
Activity of SR 142801 at peripheral tachykinin receptors
By Patacchini R. Bartho L. Holzer P. Maggi C.A.
European Journal of Pharmacology, Vol. 278, Iss. 1, 1995-05 ,pp. :